Medicare Rx Data May Be Difficult To Interpret, Merck Exec Cautions
Executive Summary
Drawing conclusions about drug safety and outcomes from Medicare prescription drug data needs to be done with caution, Merck VP-Outcomes Research & Management Marc Berger told a Centers for Medicare & Medicaid Services "Open Door Forum" June 13